• 1
    Lamm DL, Van Der Meijdem APM, Akaza H et al. Intravesical chemotherapy and immunotherapy: How do we assess their effectiveness and what are their limitations and uses? Int. J. Urol. 1995; 2 (Suppl. 2): 2335.
  • 2
    Akaza H, Kurth KH, Williams S et al. Intravesical chemotherapy and immunotherapy for superficial tumors: Basic mechanism of action and future direction. Urologic Oncol. 1998; 4: 1219.
  • 3
    Alexandroff AB, Jackson AM, O’Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999; 353: 168994.
  • 4
    Akaza H, Iwasaki A, Ohtani M, Ikeda N, Niijima K, Toida I. Expression of antitumor response: Role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells. Cancer 1993; 72: 55863.
  • 5
    Liu SQ, Saijo K, Todoroki K, Ohno T. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumor sections. Nature Med. 1995; 1: 26771.
  • 6
    Boccafoscchi C, Montefiore F, Pavesti M, Pastormerlo M, Betta PG. Late effects of intravesical Bacillus Calmette-Guérin immunotherapy on bladder mucosa on filtrating lymphocytes: An immunohistochemical study. Eur. Urol. 1995; 27: 3348.
  • 7
    Stefanini GF, Bercovich E, Mazzeo V et al. Class I and class II HLA antigen expression by transitional cell by Bacillus Calmette-Guérin carcinoma of the bladder: Correlation with T-cell infiltration and BCG treatment. J. Urol. 1989; 141: 144953.
  • 8
    Jackson AM, Alexandroff AB, Mclintyre M, Esuvaranathan K, James K, Chisholm GD. BCG immunotherapy induces ICAM-1 expression on bladder tumors. J. Clin. Pathol. 1994; 47: 30912.
  • 9
    Ratliff TL, Gillen D, Catalona WJ. Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. J. Urol. 1987; 137: 1578.
  • 10
    Reichert DF, Lamm DL. Long-term protection in bladder cancer following intralesional immunotherapy. J. Urol. 1984; 132: 5703.
  • 11
    Cornel EB, Van Moorselaar PJA, Van Stratum FMJ. Antitumor effects of bacillus Calmette-Guérin in a syngeneic rat bladder tumor model system, RBT 323. J. Urol. 1993; 149: 17982.
  • 12
    Kuroda K, Brown EJ, Telle WB, Russell DG, Ratliff TL. Characterization of the internalization of bacillus Calmette-Guérin by human bladder tumor cell. J. Clin. Invest. 1993; 91: 6976.
  • 13
    Ikeda N, Toida I, Yamada H, Iwasaki A, Akaza H. Interaction of BCG with bladder tumor cells. Biotherapy 1996; 10: 87984.
  • 14
    Ikeda N, Toida I, Iwasaki A, Kawai K, Akaza H. Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guérin (BCG): A role of BCG internalization into tumor cells. Int. J. Urol. (in press).
  • 15
    Lattime EC, Gomella LG, McCue PA. Murine bladder carcinoma cells present antigens to BCG-specific CD4+ T-cells. Cancer Res. 1992; 52: 428690.